A Shocking Shot: China's Latest Vaccine Forgery More Problematic Than Ever
Just when a fragile sector has barely regained its footing, a new vaccine scandal in China has and come into the national spotlight, and some underlying issues this time could go beyond distribution negligence and regulatory non-compliance.
You may also be interested in...
If the US FDA could track production, it could anticipate shortages – and national security threats from countries like China.
Record-breaking fine slapped on scandal-hit domestic vaccine maker in China has some wondering if the tide of opinion may be turning against private companies.
“Winning the war without fighting. Using five types of fire attacks.” Sounds familiar? Sun Tzu's 2,000 year-old wisdom on the art of war is echoing down the ages, and winning in China today means that pharma needs to embrace a digital strategy more than ever before.